Abstract:Obesity, a widespread health concern characterized by the excessive accumulation of body fat, is a complex condition influenced by genetics, environment, and social determinants. Recent research has increasingly focused on the role of gut microbiota in obesity, highlighting its pivotal involvement in various metabolic processes. The gut microbiota, a diverse community of microorganisms residing in the gastrointestinal tract, interacts with the host in a myriad of ways, impacting energy metabolism, appetite regulation, inflammation, and the gut-brain axis. Dietary choices significantly shape the gut microbiota, with diets high in fat and carbohydrates promoting the growth of harmful bacteria while reducing beneficial microbes. Lifestyle factors, like physical activity and smoking, also influence gut microbiota composition. Antibiotics and medications can disrupt microbial diversity, potentially contributing to obesity. Early-life experiences, including maternal obesity during pregnancy, play a vital role in the developmental origins of obesity. Therapeutic interventions targeting the gut microbiota, including prebiotics, probiotics, fecal microbiota transplantation, bacterial consortium therapy, and precision nutrition, offer promising avenues for reshaping the gut microbiota and positively influencing weight regulation and metabolic health. Clinical applications of microbiota-based therapies are on the horizon, with potential implications for personalized treatments and condition-based interventions. Emerging technologies, such as next-generation sequencing and advanced bioinformatics, empower researchers to identify specific target species for microbiota-based therapeutics, opening new possibilities in healthcare. Despite the promising outlook, microbiota-based therapies face challenges related to microbial selection, safety, and regulatory issues. However, with ongoing research and advances in the field, these challenges can be addressed to unlock the full potential of microbiota-based interventions.

Diet patterns, gut microbiota and metabolic disorders: Perspectives and challenges

Gut microbiota, obesity and metabolic disorders

Gut microbiota in obesity and metabolic disorders

Is the Gut Microbiota a New Factor Contributing to Obesity and Its Metabolic Disorders?

Gut Microbiome and Its Impact on Obesity and Obesity-Related Disorders

Advances in Gut Microbiota-Targeted Therapeutics for Metabolic Syndrome

The Role of the Gut Microbiota in Energy Metabolism and Metabolic Disease

Gut microbes in metabolic disturbances. Promising role for therapeutic manipulations?

Importance of gut microbiota in obesity

Exploring the Gut Microbiota: Key Insights into Its Role in Obesity, Metabolic Syndrome, and Type 2 Diabetes

Diet-gut microbiota-epigenetics in metabolic diseases: From mechanisms to therapeutics

Diets, Gut Microbiota and Metabolites

Role of the intestine and its gut microbiota in metabolic syndrome and obesity

The complex link between the gut microbiome and obesity-associated metabolic disorders: Mechanisms and therapeutic opportunities

Gut Microbiome, Diabetes, and Obesity: Complex Interplay of Physiology

Functional Dynamics of Gut Microbiota in Obesity and Metabolic Diseases

Obesity, Gut Microbiota, and Metabolome: From Pathophysiology to Nutritional Interventions

Beyond Diet and Exercise: The Impact of Gut Microbiota on Control of Obesity

High Fat Diet, Gut Microbiota and Metabolic Health

Diet, gut microbes and metabolic diseases

Obesity and the gut microbiota: implications of neuroendocrine and immune signaling